U.S. firms announce share sales and product updates
Tap title to read story
San Jose, Calif. — On April 6, 2026, selling stockholders affiliated with Blackstone announced plans to offer 11,000,000 Class A shares of Legence Corp. in a secondary underwritten public offering, with Goldman Sachs, Jefferies and BofA named as joint lead managers and a 30-day option for additional shares.
Arlington, Va., Frederick, Md., and Miami report related activity this week: Fluence reaffirmed U.S.-manufactured products qualify for domestic-content tax credits under the One Big Beautiful Bill Act; TOMI reported about a dozen SteraMist partnerships amid tighter pharmacy regulations; Real Brokerage set a May 7, 2026, Q1 results call.
More context
Timeline
- 1. April 6, 2026 — Legence announces selling stockholders affiliated with Blackstone intend to offer 11,000,000 Class A shares.
- 2. April 6, 2026 — Underwriters named: Goldman Sachs, Jefferies and BofA; 30-day option for 1,650,000 additional shares disclosed.
- 3. April 6, 2026 — Fluence Energy confirms U.S.-manufactured products remain eligible for domestic-content tax credits under the One Big Beautiful Bill Act.
- 4. April 6, 2026 — TOMI announces approximately a dozen SteraMist partnerships driven by tighter compounding pharmacy regulations and USP standards.
- 5. May 7, 2026 — The Real Brokerage will release first-quarter 2026 financial results and host a conference call at 8:00 a.m. ET.
Why it matters
The Blackstone-affiliated stock sale could affect Legence Corp's share price. If you own their stock, keep an eye on it. Fluence's tax credit eligibility means their U.S.-made products might stay cost-friendly. TOMI's SteraMist partnerships could impact pharmacy safety standards.
Sources
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.
